Ocean Biomedical, Inc.
Data quality: 83%
OCEA
OTC
Manufacturing
Chemicals
$0.00
$0.00
(0.00%)
Mkt Cap: 69,709.0
Price
$0.00
Mkt Cap
69,709.0
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -4.05 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-2.42
Valuation
PE (TTM)
0.00
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1366 peers)
Peer Comparison
vs Manufacturing sector median (1366 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.0 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q32023 | N/A | -$0.52 | — |
| Q22023 | -$0.20 | -$0.41 | -112.6% |
| Q12023 | -$0.17 | -$0.27 | -60.6% |
| Q42022 | -$0.16 | N/A | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -30.72 M |
| ROE | N/A | ROA | -2263.74% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4.05 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.06 |
| Interest Coverage | -2.42 | Asset Turnover | N/A |
| Working Capital | -25.08 M | Tangible Book Value | -92.40 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.00 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5811.30% | ||
| Market Cap | 69,709.0 | Enterprise Value | 69,709.0 |
| Per Share | |||
| EPS (Diluted TTM) | -0.91 | Revenue / Share | N/A |
| FCF / Share | -0.02 | OCF / Share | -0.02 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 13.19% |
| SBC-Adj. FCF | -4.24 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | -9.48 M | -114.47 M | -958,430.0 | -564,110.0 |
| EPS (Diluted) | -0.34 | -4.35 | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -3.80 M | -10.21 M | -2.48 M | -566,558.0 |
| EBITDA | — | — | — | — |
| R&D Expenses | 26,000.0 | 709,000.0 | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | -2.05 M | 50,000.0 | 691.0 | — |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|
| Total Assets | 902,000.0 | 5.50 M | 108.65 M | 110.91 M |
| Total Liabilities | 98.52 M | 96.26 M | 3.40 M | 6.61 M |
| Shareholders' Equity | -97.62 M | -90.76 M | -1.84 M | -6.15 M |
| Total Debt | 3.20 M | 3.20 M | — | — |
| Cash & Equivalents | — | — | 0.0 | — |
| Current Assets | 812,000.0 | 2.11 M | 1.55 M | 467,989.0 |
| Current Liabilities | 33.89 M | 30.01 M | 246,444.0 | 3.46 M |
{"event":"ticker_viewed","properties":{"ticker":"OCEA","listing_kind":"stock","pathname":"/stocks/ocea","exchange":"OTC","country":"US"}}